SPECIALIST AREAS

Associate Professor David Pryor is a Radiation Oncologist specialising in the management of urological cancers, gastrointestinal cancers and bone/soft tissue tumours (sarcomas).

He is the clinical lead for the stereotactic body radiotherapy (SBRT) program at the Princess Alexandra Hospital, implementing SBRT for prostate, liver and kidney cancers. 

EDUCATION

Associate Professor Pryor completed his medical degree with honours at the University of Queensland in 2001 and was awarded his fellowship of the Royal Australian and New Zealand College of Radiologists (RANZCR), Faculty of Radiation Oncology, in 2011.

He is the Deputy Director of Radiation Oncology and Director of Training in Radiation Oncology at the Princess Alexandra Hospital, (Ipswich Road Campus), an Adjunct Associate Professor with the Australian Prostate Cancer Research Centre, Queensland University of Technology (QUT) and a Senior Lecturer with the School of Medicine, University of Queensland. Dr Pryor has been an examiner and member of the curriculum development team for the RANZCR Faculty of Radiation Oncology.

RESEARCH & PUBLICATIONS

Associate Professor Pryor has an active clinical research program with special interests in precision radiotherapy (including SBRT), its combination with systemic agents and the incorporation of functional imaging to guide radiation treatment and response.

He has collaborations with the Australia Prostate Cancer Research Centre with a focus on quality improvement through clinical outcome registries and pre-clinical models of precision radiotherapy.

He has also been actively involved in developing collaborative, multicentre clinical trials evaluating SBRT in the management of prostate, liver, lung, breast and kidney cancers and is the current chair of the Genitourinary Committee of the Trans-Tasman Radiation Oncology collaborative trials group (TROG).

AWARDS & MEMBERSHIPS

Associate Professor Pryor sits on a number of state and national scientific advisory and quality improvement committees for prostate cancer, sarcomas and gastrointestinal cancers.

As the clinical lead for the Prostate Cancer Outcomes Registry (PCOR) in Queensland and member of the PCOR-ANZ national steering committee he is involved in developing and monitoring quality indicators to measure the standard of care provided to prostate cancer patients in Australia.

He is also a member of the Radiation Oncology Sub-committee of the Queensland Cancer Control Safety and Quality Partnership.